Medications That Change Dental Management
🚨A Complete Guide for UK Dental Practices
A comprehensive UK dental guide to medications that significantly impact dental treatment, including anticoagulants, bisphosphonates, steroids, diabetes drugs, immunosuppressants, epilepsy medication, and amlodipine. Learn risks, management, and clinical signs.
Introduction
In modern dental practice, medical history is no longer a formality—it is a clinical safeguard. With an ageing population and increasing polypharmacy, dentists in the UK are encountering more patients whose medications directly influence dental care, healing, and risk management.
Certain drug classes have a disproportionately large impact on dental treatment planning, particularly when it comes to:
-
Bleeding risk
-
Infection risk
-
Healing capacity
-
Drug interactions
-
Oral side effects
Understanding these medications is essential not only for safe practice, but also for:
-
Passing dental exams (e.g. ORE, LDS, MFDS)
-
Meeting GDC standards
-
Following SDCEP and NICE guidelines
This guide focuses on the key medication groups every UK dental professional must recognise and manage appropriately.

1. Anticoagulants and Antiplatelets
Why They Matter in Dentistry
Anticoagulants and antiplatelets are among the most clinically significant drugs in dentistry due to their effect on haemostasis. Poor management can lead to:
-
Prolonged bleeding
-
Post-operative complications
-
Medical emergencies
Common medications include:
-
Warfarin
-
DOACs (Direct Oral Anticoagulants): Apixaban, Rivaroxaban, Dabigatran, Edoxaban
-
Antiplatelets: Aspirin, Clopidogrel, Ticagrelor
Dental Considerations (UK Guidance)
According to SDCEP guidance:
-
Do NOT routinely stop anticoagulants for dental procedures
-
Check INR for warfarin patients (should be ≤4.0 within 24–72 hours)
-
Use local haemostatic measures:
-
Sutures
-
Haemostatic packs
-
Tranexamic acid mouthwash
-
Signs and Symptoms Relevant to Dentistry
| Clinical Feature | What You May See | Dental Implication |
|---|---|---|
| Prolonged bleeding | Bleeding lasting >20 minutes post-extraction | Requires local haemostasis and monitoring |
| Spontaneous gingival bleeding | Bleeding without provocation | May indicate excessive anticoagulation |
| Bruising (ecchymosis) | Facial or intraoral bruising | Increased bleeding tendency |
| Blood-filled saliva | Persistent oozing post-treatment | Requires intervention |
Key Risks
-
Post-extraction haemorrhage
-
Drug interactions (e.g. with NSAIDs, metronidazole)
-
Patient anxiety due to bleeding
2. Bisphosphonates and MRONJ
Why They Matter
Bisphosphonates are associated with Medication-Related Osteonecrosis of the Jaw (MRONJ)—a serious and potentially life-altering condition.
Common drugs:
-
Alendronic acid
-
Risedronate
-
Zoledronic acid (IV, higher risk)
Dental Considerations
According to SDCEP and NICE:
-
Avoid invasive procedures where possible
-
Emphasise preventive dentistry
-
Obtain informed consent before extractions
-
Consider referral for high-risk patients
Signs and Symptoms of MRONJ
| Clinical Feature | What You May See | Dental Implication |
|---|---|---|
| Exposed bone | Non-healing bone visible >8 weeks | Diagnostic feature of MRONJ |
| Pain or swelling | Localised jaw discomfort | Early sign of pathology |
| Loose teeth | Without periodontal cause | Possible underlying bone necrosis |
| Suppuration | Pus discharge | Secondary infection |
| Paraesthesia | Numbness of lip/chin | Advanced disease |
Key Risks
-
Poor healing after extraction
-
Chronic infection
-
Litigation risk if not consented properly
3. Corticosteroids
Why They Matter
Steroids affect:
-
Immune response
-
Healing
-
Stress response
Common drugs:
-
Prednisolone
-
Dexamethasone
Dental Considerations
Patients on long-term steroids may require:
-
Stress dose steroids for major procedures
-
Careful infection monitoring
-
Awareness of adrenal suppression
Signs and Symptoms
| Clinical Feature | What You May See | Dental Implication |
|---|---|---|
| Delayed healing | Slow socket healing | Increased review needed |
| Increased infection risk | Recurrent oral infections | Consider prophylaxis in high-risk cases |
| Cushingoid appearance | Moon face, central obesity | Indicator of long-term steroid use |
| Oral candidiasis | White plaques | Common side effect |
Key Risks
-
Adrenal crisis (rare but serious)
-
Post-operative infection
-
Poor wound healing
4. Diabetes Medications
Why They Matter
Diabetes is one of the most important systemic diseases affecting oral health.
Common medications:
-
Metformin
-
Insulin
-
SGLT2 inhibitors
Dental Considerations
Poorly controlled diabetes leads to:
-
Increased infection risk
-
Delayed healing
-
Periodontal disease progression
Follow NICE guidance:
-
Check HbA1c where relevant
-
Morning appointments preferred
-
Ensure patient has eaten before treatment
Signs and Symptoms
| Clinical Feature | What You May See | Dental Implication |
|---|---|---|
| Xerostomia | Dry mouth | Increased caries risk |
| Periodontal disease | Bleeding gums, bone loss | Poor glycaemic control indicator |
| Delayed healing | Slow recovery post-extraction | Requires monitoring |
| Oral infections | Candidiasis, abscesses | Higher prevalence |
| Hypoglycaemia | Sweating, confusion, tremor | Medical emergency risk |
Key Risks
-
Hypoglycaemic episodes in chair
-
Severe periodontal disease
-
Increased post-op complications
5. Immunosuppressants
Why They Matter
These drugs reduce immune function, increasing risk of:
-
Infection
-
Malignancy
-
Poor healing
Common medications:
-
Methotrexate
-
Azathioprine
-
Ciclosporin
-
Biologics
Dental Considerations
-
Avoid treating during neutropenic phases
-
Liaise with GP or specialist if unsure
-
Maintain excellent oral hygiene support
Signs and Symptoms
| Clinical Feature | What You May See | Dental Implication |
|---|---|---|
| Recurrent infections | Frequent oral infections | Delayed or modified treatment |
| Ulceration | Persistent oral ulcers | May require investigation |
| Gingival overgrowth (ciclosporin) | Enlarged gums | Plaque retention risk |
| Delayed healing | Slow tissue repair | Monitor closely |
Key Risks
-
Severe infections
-
Opportunistic infections
-
Compromised healing
6. Epilepsy Medications
Why They Matter
Epilepsy medications can:
-
Affect oral tissues
-
Influence treatment safety
-
Require emergency preparedness
Common drugs:
-
Phenytoin
-
Sodium valproate
-
Carbamazepine
Dental Considerations
-
Ensure seizure history is up to date
-
Avoid triggers (stress, pain)
-
Have emergency protocol ready
Signs and Symptoms
| Clinical Feature | What You May See | Dental Implication |
|---|---|---|
| Gingival hyperplasia (phenytoin) | Enlarged gingiva | Difficult oral hygiene |
| Trauma | Fractured teeth, tongue biting | Common in seizure patients |
| Xerostomia | Dry mouth | Increased caries risk |
| Drowsiness | Sedation | Affects consent and cooperation |
Key Risks
-
Seizure during treatment
-
Airway compromise
-
Oral trauma
7. Amlodipine and Gingival Enlargement
Why It Matters
Amlodipine, a calcium channel blocker, is a common cause of drug-induced gingival overgrowth.
Dental Considerations
-
Emphasise excellent oral hygiene
-
Consider liaising with GP for medication review
-
Periodontal management is key
Signs and Symptoms
| Clinical Feature | What You May See | Dental Implication |
|---|---|---|
| Gingival enlargement | Bulky, fibrous gums | Plaque retention |
| Bleeding gums | Inflamed tissue | Periodontal risk |
| Aesthetic concerns | Visible overgrowth | Patient dissatisfaction |
| Difficulty cleaning | Food trapping | Increased disease risk |
Key Risks
-
Periodontal disease
-
Patient discomfort
-
Need for surgical intervention
Practical Summary for Dental Teams
High-Risk Medication Checklist
Before any invasive procedure, ask:
-
Is the patient on anticoagulants? → bleeding risk
-
Are they taking bisphosphonates? → MRONJ risk
-
Do they use steroids or immunosuppressants? → infection risk
-
Do they have diabetes? → healing risk
-
Are they on phenytoin or amlodipine? → gingival changes
What medications affect dental treatment the most?
The medications that most significantly affect dental treatment include:
-
Anticoagulants and antiplatelets (bleeding risk)
-
Bisphosphonates (risk of jaw osteonecrosis)
-
Steroids (impaired healing and immune response)
-
Diabetes medications (healing and infection risk)
-
Immunosuppressants (infection risk)
-
Epilepsy medications (gingival overgrowth and seizure risk)
-
Amlodipine (gingival enlargement)
Conclusion
Modern dentistry is no longer just about teeth—it is about whole-patient care. Understanding how medications influence dental management is essential for:
-
Safe clinical practice
-
Regulatory compliance (GDC, CQC)
-
Improved patient outcomes
By recognising the key drug groups outlined in this guide, UK dental professionals can:
-
Reduce complications
-
Improve treatment planning
-
Deliver safer, more effective care

